Publications found:
57,145
Sort by:
The 2011 Leading Semiconductor Companies Collaborative Arrangements
US$ 1,480.00
... ventures, product development and marketing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
61 pages
The 2011 Leading Semiconductor Companies Financial Analyses
US$ 1,480.00
... Sales and operating profit by division, geographic region, market segment and product line. Five-year sales and operating profit performance. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. Contains 77 ...
October 2010
77 pages
The 2011 Leading Semiconductor Companies R&D Expenditures and Major Programs
US$ 1,480.00
... each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and line extensions in development. The companies analyzed in the report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. ...
October 2010
36 pages
The 2011 Leading Semiconductor Companies Product Portfolio Analyses
US$ 1,480.00
... US$ 3,900.00 For each company, the analyses present: Review of major product lines. Recent product introductions and line extensions. The companies analyzed in this report: Freescale, Infineon, Intel, NEC, NXP/Philips, Renesas, Samsung, STMicroelectronics, Texas Instruments, and Toshiba. Contains 130 ...
October 2010
130 pages
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan
US$ 23,520.00
The 2011 Clinical Chemistry And Immunodiagnostics Markets: US, Europe, Japan - Product Development Opportunities And Business Expansion Strategies For Instrument And Reagent Suppliers During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation. The ...
June 2010
1115 pages
The 2011 Leading Orthopedics Companies R&D Expenditures and Major Programs
US$ 1,480.00
... 3,900.00 Each company's analysis provides: R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 30 ...
May 2010
30 pages
The 2011 Leading Orthopedics Companies Facilities and Employees
US$ 1,480.00
... R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international workforce size and distribution. The companies analyzed in the report: Aesculap, Biomet, ConMed, J&J, Medtronic, Smith & Nephew, Stryker, Synthes, Wright Medical, and Zimmer. Contains 40 ...
May 2010
40 pages
Infectious Disease Molecular Diagnostic Testing
US$ 2,000.00
Global PDF: US$ 5,500.00 The report presents an overview of the clinical significance and market needs for major infectious diseases, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. Contains 360 pages and 20 tables
February 2010
360 pages
The 2011 Top Ten World's Leading Animal Health Companies
US$ 10,000.00
... include: To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world's leading animal health companies. To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors. ...
January 2010
400 pages
The 2011 Leading Animal Health Companies Financial Analyses
US$ 1,560.00
Global PDF: US$ 4,300.00 Each company analysis provides: Sales of animal health products by division, product line, geographic region and country. Five-year sales and operating profit performance. The companies analyzed in the report: Akzo/Intervet, ...
January 2010
65 pages
The 2011 Leading Animal Health Companies R&D Expenditures and Major Programs
US$ 1,360.00
Global PDF: US$ 3,700.00 Each company analysis provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in R&D, including their development phase and introduction dates. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly, Fort ...
January 2010
75 pages
The 2011 Leading Animal Health Companies Facilities and Employees
US$ 1,200.00
Global PDF: US$ 3,300.00 Each company analysis provides: Major administrative, manufacturing and R&D facilities in the U.S. and abroad. Manufacturing practices. New plants under construction. U.S. and international work force. The companies analyzed in the report: Alpharma, Bayer, Elanco/Eli Lilly ...
January 2010
40 pages
